AVENTURA, Fla., Dec. 28, 2011 /PRNewswire/ -- Fuse Science Inc. (OTCQB: DROP) (www.fusescience.com) announced today that it had formally changed its corporate name from "Double Eagle Holdings, Ltd." to "Fuse Science Inc."
The news of the name change completion comes on the heels of an announcement of a formal launch of its Hypoglycemic, Hyperglycemic, and Analgesic project platforms which are designed for the advancement of its OTC and pharmaceutical licensing efforts which are currently under way.
The company is also poised for the launch of its EnerJelT product on December 30, 2011 at www.poweredbyfuse.com.
"The corporate name change provides for the strategic alignment and execution of our business strategy with more clarity on what it means to be Powered by FuseT," said Brian Tuffin, Chief Executive Officer. "We are a very focused company with proprietary sublingual and transdermal delivery system technology. We are advancing quickly with the launch of our transdermal EnerjelT product this week and three project platforms that we expect will accelerate current licensing discussions. We believe our technology is too important to treat any other way and we are solely focused on building significant long term value for shareholders and these are further steps in that direction."
About Fuse Science Inc.
Fuse Science Inc. (OTCQB: DROP), formerly known as Double Eagle Holdings Ltd., is an innovative consumer products holding company based in Aventura, Florida. Fuse Science is the developer of new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The company has successfully developed and maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com or by calling 305-503-FUSE (3873).
Safe Harbor Statement: Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.
SOURCE Fuse Science Inc.